Cargando…

Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy

Interleukin-13 receptor subunit alpha-2 (IL-13Rα2, CD213A), a high-affinity membrane receptor of the anti-inflammatory Th2 cytokine IL-13, is overexpressed in a variety of solid tumors and is correlated with poor prognosis in glioblastoma, colorectal cancer, adrenocortical carcinoma, pancreatic canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knudson, Karin M., Hwang, SuJin, McCann, Mondona S., Joshi, Bharat H., Husain, Syed R., Puri, Raj K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023787/ https://www.ncbi.nlm.nih.gov/pubmed/35464460 http://dx.doi.org/10.3389/fimmu.2022.878365

Ejemplares similares

Generation of interleukin-13 receptor alpha2 antigen expressing modified vaccinia ankara recombinant virus for potential cancer immunotherapy
por: Sato, Yuki, et al.
Publicado: (2014)

Histone deacetylase inhibitiors enhance sensitivity of murine sarcoma tumors to IL-13-PE immunotoxin-based cancer therapy by upregulating IL-13Rα2 expression in vitro and in vivo
por: Fujisawa, Toshio, et al.
Publicado: (2013)

Interleukin 13 receptor alpha 2 directed immunotherapy targets hepatic fibrosis and tumorigenesis induced by choline deficient diet in an in vivo mouse model of nonalcoholic steatohepatitis
por: Fujisawa, Toshio, et al.
Publicado: (2014)

Identification of a novel role of IL-13Rα2 in human Glioblastoma multiforme: interleukin-13 mediates signal transduction through AP-1 pathway
por: Bhardwaj, Rukmini, et al.
Publicado: (2018)

In Vivo Overexpression of IL-13 Receptor α2 Chain Inhibits Tumorigenicity of Human Breast and Pancreatic Tumors in Immunodeficient Mice
por: Kawakami, Koji, et al.
Publicado: (2001)

Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancer
por: Fujisawa, Toshio, et al.
Publicado: (2011)

IL-13Rα2 Is a Biomarker of Diagnosis and Therapeutic Response in Human Pancreatic Cancer
por: Fujisawa, Toshio, et al.
Publicado: (2021)

Characterization of Chimeric Antigen Receptor Modified T Cells Expressing scFv-IL-13Rα2 after Radiolabeling with 89Zirconium Oxine for PET Imaging
por: Leland, Pamela, et al.
Publicado: (2023)

Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with (89)Zirconium oxine for PET imaging
por: Leland, Pamela, et al.
Publicado: (2023)

Correction: Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with (89)Zirconium oxine for PET imaging
por: Leland, Pamela, et al.
Publicado: (2023)

Interleukin-13 receptor α2 DNA prime boost vaccine induces tumor immunity in murine tumor models
por: Nakashima, Hideyuki, et al.
Publicado: (2010)

4395 alpha-Synuclein Induced Reactive Gliosis
por: Carey, Sean David, et al.
Publicado: (2020)

IL-13Rα2 gene expression is a biomarker of adverse outcome in patients with adrenocortical carcinoma
por: Kumar, Abhinav, et al.
Publicado: (2021)

Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα Signaling Complex but Not the IL-13/IL-13Rα2 Complex
por: Tollenaere, Maxim A.X., et al.
Publicado: (2023)

Analysis of interleukin-13 receptor alpha2 expression as a prognostic biomarker in surgically resected pancreatic cancer patients
por: Fujisawa, Toshio, et al.
Publicado: (2015)

Engineered IL13 variants direct specificity of IL13Rα2-targeted CAR T cell therapy
por: Stern, Lawrence A., et al.
Publicado: (2022)

Interleukin-4 receptor targeted immunotherapy of human bladder cancer in animal models
por: Joshi, Bharat H, et al.
Publicado: (2014)

Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling
por: Hall, Bradford, et al.
Publicado: (2013)

Immunotherapy in Melanoma: Recent Advances and Future Directions
por: Knight, Andrew, et al.
Publicado: (2023)

Immunotherapy in Melanoma: Recent Advancements and Future Directions
por: Mooradian, Meghan J., et al.
Publicado: (2023)

Enhanced Interleukin (IL)-13 Responses in Mice Lacking IL-13 Receptor α 2
por: Wood, Nancy, et al.
Publicado: (2003)

IL-13Rα2 Glycosylation Holds the Dance Card for Partnering with IL-13
por: Dy, Alane B. C., et al.
Publicado: (2020)

Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Rα, IL-13Rα1, and γc regulates relative cytokine sensitivity
por: Junttila, Ilkka S., et al.
Publicado: (2008)

Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma
por: Sadozai, Hassan, et al.
Publicado: (2017)

Scratching Counteracts IL-13 Signaling by Upregulating the Decoy Receptor IL-13Rα2 in Keratinocytes
por: Ulzii, Dugarmaa, et al.
Publicado: (2019)

Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme
por: Han, Jing, et al.
Publicado: (2017)

IL4Rα and IL13Rα1 Are Involved in the Development of Human Gallbladder Cancer
por: Ahn, Sung Woo, et al.
Publicado: (2022)

The IL-13/IL-4Rα axis is involved in tuberculosis-associated pathology
por: Heitmann, Lisa, et al.
Publicado: (2014)

IL13Rα2 signaling in colorectal cancer
por: Bartolomé, Rubén A., et al.
Publicado: (2015)

Apolipoprotein E4 impairs spontaneous blood brain barrier repair following traumatic brain injury
por: Main, Bevan S., et al.
Publicado: (2018)

IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma
por: Rechberger, Julian S., et al.
Publicado: (2022)

IL-13 signaling via IL-13Rα(2) triggers TGF-β(1)-dependent allograft fibrosis
por: Brunner, Stefan M, et al.
Publicado: (2013)

Myeloid-IL4Rα is an indispensable link in IL-33-ILCs-IL-13-IL4Rα axis of eosinophil recruitment in murine lungs
por: Patial, Sonika, et al.
Publicado: (2021)

Future directions for immunotherapy in meningioma treatment
por: Rutland, John W., et al.
Publicado: (2021)

Thermal ablation and immunotherapy for hepatocellular carcinoma: Recent advances and future directions
por: Bo, Xiao-Wan, et al.
Publicado: (2021)

Lack of association or interactions between the IL-4, IL-4Rα and IL-13 genes, and rheumatoid arthritis
por: Marinou, Ioanna, et al.
Publicado: (2008)

IL-15/IL-15Rα Heterodimeric Complex as Cancer Immunotherapy in Murine Breast Cancer Models
por: Guo, Siqi, et al.
Publicado: (2021)

A novel multimeric IL15/IL15Rα-Fc complex to enhance cancer immunotherapy
por: Xu, Hong, et al.
Publicado: (2021)

Targeting interleukin-13 receptor α2 (IL-13Rα2) for glioblastoma therapy with surface functionalized nanocarriers
por: Liang, Ruijia, et al.
Publicado: (2022)

The effect of IL-13 and IL-13R130Q, a naturally occurring IL-13 polymorphism, on the gene expression of human airway smooth muscle cells
por: Syed, Farhat, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_4r280ngdhhtjliiflh9m3cgq8n